Pfizer Inc. (PFE) — Stock Price, Chart & Analysis
Pfizer Inc. (PFE) is a Healthcare stock currently trading at $26.76, up 1.06% on the day. It carries a market capitalization of $152.52B and a trailing P/E ratio of 34.31. Over the past 52 weeks, PFE has traded between $23.58 and $28.75. Pfizer Inc. pays a dividend yielding 6.6%. View the live PFE chart, technical opinion, analyst ratings, fundamentals and latest news below.
Pfizer Inc. (PFE) key data
| Price | $26.76 |
| Change (today) | +1.06% |
| Previous close | $26.48 |
| Market cap | $152.52B |
| P/E ratio (TTM) | 34.31 |
| EPS (TTM) | $0.78 |
| Dividend yield | 6.6% |
| 52-week high | $28.75 |
| 52-week low | $23.58 |
| Beta | 0.28 |
| Avg. volume | 41.89M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about Pfizer Inc. (PFE)
How much does one share of Pfizer Inc. cost?
As of the latest update, one share of Pfizer Inc. (PFE) trades at $26.76 (+1.06% today).
What is Pfizer Inc.'s market cap?
Pfizer Inc. has a market capitalization of approximately $152.52B.
What is Pfizer Inc.'s P/E ratio?
Pfizer Inc. has a trailing price-to-earnings (P/E) ratio of 34.31.
What is Pfizer Inc.'s earnings per share (EPS)?
Pfizer Inc.'s trailing twelve-month EPS is $0.78.
Does Pfizer Inc. pay a dividend?
Yes — Pfizer Inc. pays a dividend with a yield of 6.6% ($1.72 per share annually).
What is Pfizer Inc.'s 52-week trading range?
Over the past year, PFE has traded between $23.58 and $28.75.
What is the analyst price target for Pfizer Inc.?
The mean analyst price target for Pfizer Inc. is $28.63. This is informational only and not investment advice.
Latest Pfizer Inc. (PFE) news
- Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's ZepboundNews · Aug 7, 2026
- The Two Divergent Paths Priced Into Eli Lilly StockNews · Aug 7, 2026
- NVAX Q2 Earnings & Sales Beat Estimates, '26 Sales Outlook RaisedNews · Aug 7, 2026
- Stock Market Pro Chooses The Best ETFs To OwnNews · Aug 7, 2026
- Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other PlayersNews · Aug 7, 2026
- Novavax Inc (NVAX) (Q2 2026) Earnings Call Highlights: Matrix-M Momentum Drives Revenue ...News · Aug 6, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live PFE dashboard…